The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabetes, heart disease, and infections. This move aims to reduce treatment costs for millions of patients managing chronic illnesses, with benefits expected to reach consumers within two to three months as new stock replaces older inventory.

NEW DELHI: Medicines used for diabetes, high blood pressure, heart disease, infections and women's health are among 30 drug formulations for which National Pharmaceutical Pricing…

The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabetes, heart disease, and infections. This…